Literature DB >> 5127070

Experimental osteomyelitis. II. Therapeutic trials and measurement of antibiotic levels in bone.

C W Norden.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5127070     DOI: 10.1093/infdis/124.6.565

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  16 in total

1.  Bone concentrations of antimicrobial agents after parenteral administration.

Authors:  J D Smilack; W H Flittie; T W Williams
Journal:  Antimicrob Agents Chemother       Date:  1976-01       Impact factor: 5.191

2.  Plasma, bone, hip capsule, synovial and drain fluid concentrations of lincomycin during total hip replacement.

Authors:  R L Parsons; J P Beavis; G A Hossack; G M Paddock
Journal:  Br J Clin Pharmacol       Date:  1977-08       Impact factor: 4.335

3.  Anti-staphylococcal gamma hemolysin antibodies in rabbits with staphylococcal osteomyelitis.

Authors:  M Kurek; K Pryjma; S Bartkowski; P B Heczko
Journal:  Med Microbiol Immunol       Date:  1977-05-18       Impact factor: 3.402

4.  Treatment of chronic experimental Staphylococcus aureus osteomyelitis with LY146032 and vancomycin.

Authors:  Q N Luu; T B Buxton; D R Nelson; J P Rissing
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-06       Impact factor: 3.267

5.  Common bacterial infections in infancy and childhood. 5. Infections of the skeletal system.

Authors:  G A Ahronheim
Journal:  Drugs       Date:  1978-09       Impact factor: 9.546

6.  In vitro comparison of netilmicin, a semisynthetic derivative of sisomicin, and four other aminoglycoside antibiotics.

Authors:  S A Kabins; C Nathan; S Cohen
Journal:  Antimicrob Agents Chemother       Date:  1976-07       Impact factor: 5.191

Review 7.  Cefepime clinical pharmacokinetics.

Authors:  M P Okamoto; R K Nakahiro; A Chin; A Bedikian
Journal:  Clin Pharmacokinet       Date:  1993-08       Impact factor: 6.447

8.  Single-dose antimicrobial prophylaxis in open heart surgery.

Authors:  T Beam; T Raab; J Spooner; S Balderman; J Aldridge; J Bhayana
Journal:  Eur J Clin Microbiol       Date:  1984-12       Impact factor: 3.267

9.  Bone penetration of enoxacin in patients with and without osteomyelitis.

Authors:  I W Fong; B R Rittenhouse; M Simbul; A C Vandenbroucke
Journal:  Antimicrob Agents Chemother       Date:  1988-06       Impact factor: 5.191

10.  Comparative evaluation of A-56619, A-56620, and nafcillin in the treatment of experimental Staphylococcus aureus osteomyelitis.

Authors:  J T Mader; L T Morrison; K R Adams
Journal:  Antimicrob Agents Chemother       Date:  1987-02       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.